Skip to main content
. 2022 Mar 9;10(3):631. doi: 10.3390/biomedicines10030631
AEA Anandamide, N-Arachidonoylethanolamine, N-Arachidonylethanolamide
2-AG 2-Arachidonoylglycerol
AraS N-Arachidonoyl-L-serine
CBC Cannabichromene
CBCA Cannabichromenic acid
CBD Cannabidiol
CBDA Cannabidiolic acid
CBG Cannabigerol
CBN Cannabinol
CFU Colony-forming unit
C. sativa L. Cannabis sativa Linnaeus
DAGL Diacylglycerol lipase
ECS Endocannabinoid system
EPS Extracellular polymeric substances
FAAH Fatty acid amide hydrolase
GPCR G-protein-coupled receptor
GPR18/GPR55 G-protein-coupled receptors 18/55
IBD Inflammatory bowel disease
IC50 Half maximal inhibitory concentration
LD50 Half maximal lethal dose
LEA N-Linoleoylethanolamine
MBEC Minimum biofilm eradication concentration
MBIC Minimum biofilm inhibitory concentration
MIC Minimum inhibitory concentration
MDRSA Multidrug resistant Staphylococcus aureus
MSSA Methicillin sensitive Staphylococcus aureus
MRSA Methicillin resistant Staphylococcus aureus
NAE N-Acylethanolamine
NAPE N-Acyl-phosphatidylethanolamine
OEA Oleoylethanolamine
OLDA N-Oleoyldopamine
PALDA N-Palmitoyldopamine
PEA Palmitoylethanolamine
PIP2 Phosphatidylinositol-4,5-bisphosphate
PPARα/γ Peroxisome proliferator activated receptor α/γ
Psmα α-Helical phenol-soluble modulin
SCFA Small chain fatty acid
STEARDA N-Stearoyldopamine
Δ9-THC Δ9-Tetrahydrocannabinol
THCA Tetrahydrocannabinolic acid
TRPA1 Ankyrin-type 1 transient receptor potential channel
TRPM8 Transient receptor potential cation channel subfamily M (melastatin) member 8
TRPV1 Transient receptor potential vanilloid-1